ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis

Cell

Volumn 161, Issue 7, 2015, Pages 1527-1538

  Cubillos Ruiz, Juan R ^a   Silberman, Pedro C ^a   Rutkowski, Melanie R ^b   Chopra, Sahil ^a   Perales Puchalt, Alfredo ^b   Song, Minkyung ^a   Zhang, Sheng ^c   Bettigole, Sarah E ^a,d   Gupta, Divya ^a   Holcomb, Kevin ^a   Ellenson, Lora H ^a   Caputo, Thomas ^a   Lee, Ann Hwee ^a   Conejo Garcia, Jose R ^b   Glimcher, Laurie H ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b WISTAR INSTITUTE   (United States)

^c Cornell University   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRIACYLGLYCEROL; X BOX BINDING PROTEIN 1; DNA BINDING PROTEIN; REGULATORY FACTOR X TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

ANTIGEN PRESENTATION; ARTICLE; CANCER CELL; CANCER IMMUNOTHERAPY; DENDRITIC CELL; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM STRESS; GENE SILENCING; HOMEOSTASIS; HUMAN; IMMUNITY; LIPID METABOLISM; LIPID STORAGE; OVARY CANCER; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR IMMUNITY; ANIMAL; C57BL MOUSE; FEMALE; IMMUNOLOGY; LIPID PEROXIDATION; METABOLISM; MOUSE; OVARY TUMOR; PATHOLOGY; TRANSGENIC MOUSE;

ANIMALS; DENDRITIC CELLS; DNA-BINDING PROTEINS; ENDOPLASMIC RETICULUM STRESS; FEMALE; HUMANS; LIPID PEROXIDATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OVARIAN NEOPLASMS; T-LYMPHOCYTES; TRANSCRIPTION FACTORS;

EID: 84931569761     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2015.05.025     Document Type: Article

References (37)

1. D. Acosta-Alvear, Y. Zhou, A. Blais, M. Tsikitis, N.H. Lents, C. Arias, C.J. Lennon, Y. Kluger, and B.D. Dynlacht XBP1 controls diverse cell type- and condition-specific transcriptional regulatory networks Mol. Cell 27 2007 53 66
2. C.M. Bollard, S. Gottschalk, A.M. Leen, H. Weiss, K.C. Straathof, G. Carrum, M. Khalil, M.F. Wu, M.H. Huls, and C.C. Chang Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer Blood 110 2007 2838 2845
3. M.L. Caton, M.R. Smith-Raska, and B. Reizis Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen J. Exp. Med. 204 2007 1653 1664
4. X. Chen, D. Iliopoulos, Q. Zhang, Q. Tang, M.B. Greenblatt, M. Hatziapostolou, E. Lim, W.L. Tam, M. Ni, and Y. Chen XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway Nature 508 2014 103 107
5. J.R. Conejo-Garcia, F. Benencia, M.C. Courreges, E. Kang, A. Mohamed-Hadley, R.J. Buckanovich, D.O. Holtz, A. Jenkins, H. Na, and L. Zhang Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A Nat. Med. 10 2004 950 958
6. L.M. Coussens, and Z. Werb Inflammation and cancer Nature 420 2002 860 867
7. J.R. Cubillos-Ruiz, X. Engle, U.K. Scarlett, D. Martinez, A. Barber, R. Elgueta, L. Wang, Y. Nesbeth, Y. Durant, and A.T. Gewirtz Polyethylenimine-based siRNA nanocomplexes reprogram tumor-associated dendritic cells via TLR5 to elicit therapeutic antitumor immunity J. Clin. Invest. 119 2009 2231 2244
8. J.R. Cubillos-Ruiz, J.R. Baird, A.J. Tesone, M.R. Rutkowski, U.K. Scarlett, A.L. Camposeco-Jacobs, J. Anadon-Arnillas, N.M. Harwood, M. Korc, and S.N. Fiering Reprogramming tumor-associated dendritic cells in vivo using miRNA mimetics triggers protective immunity against ovarian cancer Cancer Res. 72 2012 1683 1693
9. T.J. Curiel, S. Wei, H. Dong, X. Alvarez, P. Cheng, P. Mottram, R. Krzysiek, K.L. Knutson, B. Daniel, and M.C. Zimmermann Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity Nat. Med. 9 2003 562 567
10. M. De Palma, C. Murdoch, M.A. Venneri, L. Naldini, and C.E. Lewis Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications Trends Immunol. 28 2007 519 524
11. S. Galvani, C. Coatrieux, M. Elbaz, M.H. Grazide, J.C. Thiers, A. Parini, K. Uchida, N. Kamar, L. Rostaing, and M. Baltas Carbonyl scavenger and antiatherogenic effects of hydrazine derivatives Free Radic. Biol. Med. 45 2008 1457 1467
12. B.P. Gomez, R.B. Riggins, A.N. Shajahan, U. Klimach, A. Wang, A.C. Crawford, Y. Zhu, A. Zwart, M. Wang, and R. Clarke Human X-box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell lines FASEB J. 21 2007 4013 4027
13. D.L. Herber, W. Cao, Y. Nefedova, S.V. Novitskiy, S. Nagaraj, V.A. Tyurin, A. Corzo, H.I. Cho, E. Celis, and B. Lennox Lipid accumulation and dendritic cell dysfunction in cancer Nat. Med. 16 2010 880 886
14. A.C. Herrera, V.J. Victorino, F.C. Campos, B.D. Verenitach, L.T. Lemos, A.M. Aranome, S.R. Oliveira, A.L. Cecchini, A.N. Simão, and E. Abdelhay Impact of tumor removal on the systemic oxidative profile of patients with breast cancer discloses lipid peroxidation at diagnosis as a putative marker of disease recurrence Clin. Breast Cancer 14 2014 451 459
15. C. Hetz, E. Chevet, and H.P. Harding Targeting the unfolded protein response in disease Nat. Rev. Drug Discov. 12 2013 703 719
16. J. Hollien, J.H. Lin, H. Li, N. Stevens, P. Walter, and J.S. Weissman Regulated Ire1-dependent decay of messenger RNAs in mammalian cells J. Cell Biol. 186 2009 323 331
17. E. Huarte, J.R. Cubillos-Ruiz, Y.C. Nesbeth, U.K. Scarlett, D.G. Martinez, R.J. Buckanovich, F. Benencia, R.V. Stan, T. Keler, and P. Sarobe Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity Cancer Res. 68 2008 7684 7691
18. A.H. Lee, N.N. Iwakoshi, K.C. Anderson, and L.H. Glimcher Proteasome inhibitors disrupt the unfolded protein response in myeloma cells Proc. Natl. Acad. Sci. USA 100 2003 9946 9951
19. A.H. Lee, N.N. Iwakoshi, and L.H. Glimcher XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response Mol. Cell. Biol. 23 2003 7448 7459
20. A.H. Lee, E.F. Scapa, D.E. Cohen, and L.H. Glimcher Regulation of hepatic lipogenesis by the transcription factor XBP1 Science 320 2008 1492 1496
21. R.A. Morgan, M.E. Dudley, J.R. Wunderlich, M.S. Hughes, J.C. Yang, R.M. Sherry, R.E. Royal, S.L. Topalian, U.S. Kammula, and N.P. Restifo Cancer regression in patients after transfer of genetically engineered lymphocytes Science 314 2006 126 129
22. A. Negre-Salvayre, C. Coatrieux, C. Ingueneau, and R. Salvayre Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors Br. J. Pharmacol. 153 2008 6 20
23. F. Osorio, S.J. Tavernier, E. Hoffmann, Y. Saeys, L. Martens, J. Vetters, I. Delrue, R. De Rycke, E. Parthoens, and P. Pouliot The unfolded-protein-response sensor IRE-1α regulates the function of CD8α+ dendritic cells Nat. Immunol. 15 2014 248 257
24. R. Ramakrishnan, V.A. Tyurin, F. Veglia, T. Condamine, A. Amoscato, D. Mohammadyani, J.J. Johnson, L.M. Zhang, J. Klein-Seetharaman, and E. Celis Oxidized lipids block antigen cross-presentation by dendritic cells in cancer J. Immunol. 192 2014 2920 2931
25. K.F. Roby, C.C. Taylor, J.P. Sweetwood, Y. Cheng, J.L. Pace, O. Tawfik, D.L. Persons, P.G. Smith, and P.F. Terranova Development of a syngeneic mouse model for events related to ovarian cancer Carcinogenesis 21 2000 585 591
26. U.K. Scarlett, M.R. Rutkowski, A.M. Rauwerdink, J. Fields, X. Escovar-Fadul, J. Baird, J.R. Cubillos-Ruiz, A.C. Jacobs, J.L. Gonzalez, and J. Weaver Ovarian cancer progression is controlled by phenotypic changes in dendritic cells J. Exp. Med. 209 2012 495 506
27. S.P. Singh, M. Niemczyk, D. Saini, Y.C. Awasthi, L. Zimniak, and P. Zimniak Role of the electrophilic lipid peroxidation product 4-hydroxynonenal in the development and maintenance of obesity in mice Biochemistry 47 2008 3900 3911
28. S.P. Singh, M. Niemczyk, L. Zimniak, and P. Zimniak Fat accumulation in Caenorhabditis elegans triggered by the electrophilic lipid peroxidation product 4-hydroxynonenal (4-HNE) Aging 1 2009 68 80
29. R. Sriburi, S. Jackowski, K. Mori, and J.W. Brewer XBP1: a link between the unfolded protein response, lipid biosynthesis, and biogenesis of the endoplasmic reticulum J. Cell Biol. 167 2004 35 41
30. C.H. Tang, S. Ranatunga, C.L. Kriss, C.L. Cubitt, J. Tao, J.A. Pinilla-Ibarz, J.R. Del Valle, and C.C. Hu Inhibition of ER stress-associated IRE-1/XBP-1 pathway reduces leukemic cell survival J. Clin. Invest. 124 2014 2585 2598
31. K. Uchida, M. Shiraishi, Y. Naito, Y. Torii, Y. Nakamura, and T. Osawa Activation of stress signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production J. Biol. Chem. 274 1999 2234 2242
32. J.M. Velez, S. Miriyala, R. Nithipongvanitch, T. Noel, C.D. Plabplueng, T. Oberley, P. Jungsuwadee, H. Van Remmen, M. Vore, and D.K. St Clair p53 Regulates oxidative stress-mediated retrograde signaling: a novel mechanism for chemotherapy-induced cardiac injury PLoS ONE 6 2011 e18005
33. E. Vladykovskaya, S.D. Sithu, P. Haberzettl, N.S. Wickramasinghe, M.L. Merchant, B.G. Hill, J. McCracken, A. Agarwal, S. Dougherty, and S.A. Gordon Lipid peroxidation product 4-hydroxy-trans-2-nonenal causes endothelial activation by inducing endoplasmic reticulum stress J. Biol. Chem. 287 2012 11398 11409
34. T.L. Whiteside The tumor microenvironment and its role in promoting tumor growth Oncogene 27 2008 5904 5912
35. H. Yoshida, T. Matsui, A. Yamamoto, T. Okada, and K. Mori XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor Cell 107 2001 881 891
36. L. Zhang, J.R. Conejo-Garcia, D. Katsaros, P.A. Gimotty, M. Massobrio, G. Regnani, A. Makrigiannakis, H. Gray, K. Schlienger, and M.N. Liebman Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer N. Engl. J. Med. 348 2003 203 213
37. W. Zou Immunosuppressive networks in the tumour environment and their therapeutic relevance Nat. Rev. Cancer 5 2005 263 274